<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2022</study_start_year><condition></condition><condition>colorectal cancer</condition><disease></disease><disease>Colorectal Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/37789</full_dataset_link><location>China</location><study_start_month>3</study_start_month><repository>ECRIN MDR</repository><study_status>Not yet recruiting</study_status></additional><is_claimable>false</is_claimable><name>Yiqi Chupi Powder for treating chemotherapy-related fatigue after colorectal cancer surgery: a multicenter randomized controlled trial</name><description>Interventions: Experimental group:Oxaliplatin+Capecitabine+Yiqi Chupi Powder;Control group:Oxaliplatin+Capecitabine
Primary outcome(s): Piper fatigue score
Study Design: Cross-sectional</description><dates><creation>2022-03-15</creation></dates><accession>37789</accession><cross_references><Chinese Clinical Trial Register>ChiCTR2200057546</Chinese Clinical Trial Register><Chinese Medicine Clinical Trials Registry>ChiMCTR2200005712</Chinese Medicine Clinical Trials Registry><International Traditional Medicine Clinical Trial Registry>ITMCTR2200005712</International Traditional Medicine Clinical Trial Registry></cross_references></HashMap>